HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Emi Inagaki Selected Research
Emi Inagaki Research Topics
Disease
3
Dry Eye Syndromes (Dry Eye Syndrome)
11/2023 - 02/2011
2
Blindness (Hysterical Blindness)
02/2024 - 01/2021
2
Corneal Edema
01/2021 - 01/2018
1
Spinal Cord Injuries (Spinal Cord Injury)
02/2024
1
Coronary Artery Disease (Coronary Atherosclerosis)
01/2024
1
Hyperinsulinism (Hyperinsulinemia)
01/2024
1
Obesity
01/2024
1
Neoplasms (Cancer)
01/2022
1
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022
1
Fibrosis (Cirrhosis)
05/2021
1
Retinal Degeneration
01/2018
1
Extensively Drug-Resistant Tuberculosis
08/2012
1
Infections
02/2011
1
Wounds and Injuries (Trauma)
02/2011
Drug/Important Bio-Agent (IBA)
2
Retinaldehyde (Retinal)
IBA
02/2024 - 01/2018
1
Glucose (Dextrose)
FDA Link
Generic
01/2024
1
Insulin (Novolin)
FDA Link
01/2024
1
NAD (NADH)
IBA
01/2024
1
Nicotinamide Mononucleotide
IBA
01/2024
1
Excipients (Suspending Agents)
IBA
11/2023
1
Collagen Type I (Type I Collagen)
IBA
05/2021
1
Adenosine Triphosphatases (ATPase)
IBA
01/2018
1
vinaxanthone (411F)
IBA
11/2017
1
Semaphorin-3A
IBA
11/2017
1
Ditiocarb (Sodium Diethyldithiocarbamate)
FDA Link
08/2012
1
Disulfiram (Antabuse)
FDA Link
08/2012
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
02/2011
Therapy/Procedure
3
Therapeutics
01/2022 - 01/2021
1
Transplantation
01/2021
1
Hydrophilic Contact Lenses (Hydrophilic Contact Lens)
02/2011